Jonathon Nixon-Abell
British neuroscientist and cell biologist
From Wikipedia, the free encyclopedia
Jonathon Nixon-Abell (born 1988) is a British neuroscientist and cell biologist whose research focuses on the organization and dynamics of intracellular organelles, particularly in neurons. He is a group leader and Wellcome Trust Fellow in Clinical Neurosciences at the Cambridge Institute for Medical Research, at the University of Cambridge.[1]
Education and career
Nixon-Abell received his BSc in Neuroscience from University College London. He completed his PhD in Molecular Neuroscience through a joint programme between University College London and the U.S. National Institutes of Health, where his doctoral research examined endoplasmic reticulum structure and function.[2] He subsequently undertook postdoctoral research at the Howard Hughes Medical Institute's Janelia Research Campus and the University of Cambridge as a Sir Henry Wellcome Fellow, working on advanced imaging approaches to study endoplasm reticulum dynamics and organelle interactions.[3][4][5] In 2024, Nixon-Abell was awarded a Wellcome Trust Career Development Award, under which he established his independent research group at the University of Cambridge.[6][7]
Research
Nixon-Abell's research focuses on understanding how intracellular organelles are shaped, trafficked and communicate with one another, and how these processes contribute to cellular homeostasis and disease.[1][8][9][10] Nixon-Abell has also contributed to the Encyclopaedia of Cell Biology, [11] and published an opinion piece in the Financial Times discussing the importance of diversity and interdisciplinary approaches in the development of COVID-19 vaccines.[12]